Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Oct 31;2(2):180-191.
doi: 10.1016/j.ekir.2016.10.006. eCollection 2017 Mar.

Hypertension Control, Apparent Treatment Resistance, and Outcomes in the Elderly Population With Chronic Kidney Disease

Jean Kaboré  1 , Marie Metzger  1 , Catherine Helmer  2   3   4 , Claudine Berr  5   6 , Christophe Tzourio  2   3 , Tilman B Drueke  1 , Ziad A Massy  1   7 , Bénédicte Stengel  1
Affiliations

Hypertension Control, Apparent Treatment Resistance, and Outcomes in the Elderly Population With Chronic Kidney Disease

Jean Kaboré et al. Kidney Int Rep. .

Abstract

Introduction: Chronic kidney disease (CKD) is often associated with poor hypertension control and treatment resistance, but whether CKD modifies the effect of hypertension control on outcomes is unknown.

Methods: We studied 10-year mortality and cardiovascular events according to hypertension control status and CKD (glomerular filtration rate <60 ml/min/1.73m2) in 4262 community-dwelling individuals (40% men) more than 65 years of age.

Results: At baseline, 19% had CKD, and 31.2% had controlled hypertension on ≤3 antihypertensive drugs, 62.3% uncontrolled hypertension ≥140/90 mm Hg on ≤2 drugs, and 6.5% apparent treatment-resistant hypertension (aTRH) ≥140/90 mm Hg with ≥3 drugs or use of ≥4 drugs regardless of level. There were 1115 deaths (305 total cardiovascular deaths) and 274 incident nonfatal or fatal strokes or coronary events. Compared to the reference group (controlled hypertension and no CKD), participants without CKD and with uncontrolled hypertension or aTRH had adjusted hazard ratios for all-cause mortality of 0.86 (0.74-1.01) and 1.09 (0.82-1.46), and those with CKD and controlled or uncontrolled hypertension, or aTRH, of 1.33 (1.06-1.68), 1.14 (0.93-1.39), and 1.34 (0.98-1.85), respectively. Participants with aTRH and CKD had a risk of coronary death more than 3 times higher than that of the reference group; participants with aTHR, with or without CKD, had a risk of stroke more than twice as high, and those with CKD but controlled hypertension a 2 times higher risk for cardiovascular deaths from other causes.

Discussion: CKD does not appear to amplify the risk of stroke and coronary events associated with aTRH in this older population. The reasons for excess cardiovascular mortality from other causes associated with controlled hypertension require further study.

Keywords: cardiovascular; chronic kidney disease; hypertension.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flowchart of the study participants. BP, blood pressure; CHD, coronary heart disease.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Muntner P., Anderson A., Charleston J. Hypertension awareness, treatment, and control in adults with CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2010;55:441–451. - PMC - PubMed
    1. Cai G., Zheng Y., Sun X., Chen X. Prevalence, awareness, treatment, and control of hypertension in elderly adults with chronic kidney disease: results from the survey of prevalence, awareness, and treatment rates in chronic kidney disease patients with hypertension in china. J Am Geriatr Soc. 2013;61:2160–2167. - PubMed
    1. Agarwal R., Pappas M.K., Sinha A.D. Masked uncontrolled hypertension in CKD. J Am Soc Nephrol. 2015;27:1–9. - PMC - PubMed
    1. Plantinga L.C., Miller E.R., Stevens L.A. Blood pressure control among persons without and with chronic kidney disease: US trends and risk factors 1999-2006. Hypertension. 2009;54:47–56. - PMC - PubMed
    1. Rossignol P., Massy Z.A., Azizi M. The double challenge of resistant hypertension and chronic kidney disease. Lancet. 2015;386:1588–1598. - PubMed